Researchers are encouraged by results from initial safety trials of regulatory T cells in graft-versus-host disease and are embarking on trials testing their ability to fight type 1 diabetes and forestall rejection of transplanted kidneys.
No takes yet. Share an insight, caveat, or question.
Mitch Leslie (2011) studied this question.